Answers are grounded in this paper and cite their sources.
Our findings suggest that this 23% incidence of false-negative biopsies represents significant cancer. This relatively high incidence is important to consider in treatment modalities in which prostate biopsy may be performed to determine response to therapy.
No takes yet. Share an insight, caveat, or question.
Rabbani et al. (1998) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: